Streetbeat News

Analyst Ratings

ASAN

Citigroup analyst Steven Enders has reiterated a Neutral rating on Asana (NYSE:ASAN) and lowered the price target from $26 to $24.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:33 pm

APTO

Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on Aptose Biosciences (NASDAQ:APTO) and maintained a $38 price target.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:33 pm

DDOG

A significant amount of unusual options activity has been observed for Datadog (NASDAQ:DDOG), with a majority of investors taking a bullish stance. Whales have been targeting a price range from $70.0 to $120.0 for Datadog over the last 3 months. The current price of DDOG is down -2.62% at $95.11. Several financial institutions have maintained their positive ratings on Datadog, with price targets ranging from $90 to $133.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:32 pm

AMAT

A significant bearish stance has been taken on Applied Mat (NASDAQ:AMAT) with 73% of investors opening trades with bearish expectations. The majority of the spotted trades are puts, totaling $664,129. Whales have been targeting a price range from $110.0 to $155.0 for Applied Mat over the last 3 months. The price of AMAT is currently down -4.85% at $145.75. Analysts from Craig-Hallum, Berenberg, Susquehanna, Morgan Stanley, and TD Cowen have maintained their ratings on Applied Mat.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:31 pm

LVS

A significant bearish stance has been taken on Las Vegas Sands (NYSE:LVS) by a large investor, as observed from publicly available options history. The overall sentiment of these big-money traders is split between 46% bullish and 53% bearish. The whales have been targeting a price range from $45.0 to $52.5 for Las Vegas Sands over the last 3 months. The price of LVS is currently down -2.25% at $51.25.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:31 pm

ALXO

Cantor Fitzgerald analyst Alethia Young has reinstated ALX Oncology Holdings (NASDAQ:ALXO) with an Overweight rating and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:31 pm

AFMD

Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on Affimed (NASDAQ:AFMD) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:30 pm

DOCU

Citigroup analyst Tyler Radke maintains a Buy rating on DocuSign (NASDAQ:DOCU) and raises the price target from $78 to $81.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:29 pm

TW

Citigroup analyst Christopher Allen maintains a Buy rating on Tradeweb Markets (NASDAQ:TW) and raises the price target from $92 to $100.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:27 pm

MU

Citigroup analyst Christopher Danely maintains a 'Buy' rating on Micron Technology (NASDAQ:MU) and raises the price target from $75 to $85.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:25 pm